Francesco Boccardo

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. ncbi request reprint Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
    F Boccardo
    Department of Medical Oncology, National Cancer Research Institute and University of Genoa, Italy
    Int J Biol Markers 21:123-6. 2006
  2. ncbi request reprint Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines
    Francesca Argellati
    IRCCS San Martino University Hospital IST National Cancer Research Institute and the University of Genoa, Academic Unit of Medical Oncology UOC Oncologia Medica B, Largo Rosanna Benzi 10, 16132 Genoa, Italy
    Anticancer Res 33:815-20. 2013
  3. doi request reprint Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial
    Francesco Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Oncology 74:223-8. 2008
  4. ncbi request reprint Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer
    Francesco Boccardo
    Department of Oncology, Biology and Genetics, University of Genoa, Genoa, Italy
    Nat Clin Pract Oncol 5:76-7. 2008
  5. ncbi request reprint Switching to aromatase inhibitors in early breast cancer
    Francesco Boccardo
    Department of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Lancet 369:533-5. 2007
  6. ncbi request reprint Adjuvant chemotherapy of bladder cancer
    F Boccardo
    National Cancer Research Institute and University of Genoa, Genoa, Italy
    Ann Oncol 17:v129-32. 2006
  7. ncbi request reprint Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
    F Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Ann Oncol 17:vii10-4. 2006
  8. ncbi request reprint 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro
    F Boccardo
    University of Genoa, Italy
    Anticancer Res 25:4277-80. 2005
  9. ncbi request reprint Enterolactone as a risk factor for breast cancer: a review of the published evidence
    Francesco Boccardo
    University of Genoa, Genoa, Italy
    Clin Chim Acta 365:58-67. 2006
  10. ncbi request reprint Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial
    Francesco Boccardo
    National Cancer Research Institute, 16132 Genoa, Italy
    J Clin Oncol 23:5138-47. 2005

Collaborators

Detail Information

Publications58

  1. ncbi request reprint Influence of bicalutamide with or without tamoxifen or anastrozole on insulin-like growth factor 1 and binding proteins in prostate cancer patients
    F Boccardo
    Department of Medical Oncology, National Cancer Research Institute and University of Genoa, Italy
    Int J Biol Markers 21:123-6. 2006
    ..There is growing evidence that IGF-1 and binding proteins may be involved in prostate cancer promotion and progression...
  2. ncbi request reprint Dihydrotestosterone and bicalutamide do not affect periostin expression in androgen-dependent LNCaP prostate cancer cell lines
    Francesca Argellati
    IRCCS San Martino University Hospital IST National Cancer Research Institute and the University of Genoa, Academic Unit of Medical Oncology UOC Oncologia Medica B, Largo Rosanna Benzi 10, 16132 Genoa, Italy
    Anticancer Res 33:815-20. 2013
    ..To investigate periostin (POSTN) expression in the LNCaP cell line...
  3. doi request reprint Prednisone plus gefitinib versus prednisone plus placebo in the treatment of hormone-refractory prostate cancer: a randomized phase II trial
    Francesco Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Oncology 74:223-8. 2008
    ..Abnormal epidermal growth factor receptor expression and pre-clinical data prompted us to investigate the activity of gefitinib, a selective epidermal growth factor receptor tyrosine kinase inhibitor, in hormone-refractory prostate cancer...
  4. ncbi request reprint Switching to anastrozole after tamoxifen improves survival in postmenopausal women with breast cancer
    Francesco Boccardo
    Department of Oncology, Biology and Genetics, University of Genoa, Genoa, Italy
    Nat Clin Pract Oncol 5:76-7. 2008
  5. ncbi request reprint Switching to aromatase inhibitors in early breast cancer
    Francesco Boccardo
    Department of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Lancet 369:533-5. 2007
  6. ncbi request reprint Adjuvant chemotherapy of bladder cancer
    F Boccardo
    National Cancer Research Institute and University of Genoa, Genoa, Italy
    Ann Oncol 17:v129-32. 2006
    ..Optimal treatment for high risk patients includes local and perioperative systemic therapy (adjuvant or neoadjuvant chemotherapy)...
  7. ncbi request reprint Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
    F Boccardo
    The National Cancer Research Institute and the University of Genoa, Genoa, Italy
    Ann Oncol 17:vii10-4. 2006
    ..Moreover, many women relapse during or after tamoxifen therapy due to the development of resistance. This provided the rationale for a switching trial with anastrozole, the updated results of which are reported here...
  8. ncbi request reprint 4-OH tamoxifen does not interfere with bicalutamide inhibitory effects on human prostatic cancer cells in vitro
    F Boccardo
    University of Genoa, Italy
    Anticancer Res 25:4277-80. 2005
    ..The present study was aimed at investigating the effects of the co-administration of 4-OH Tamoxifen (4HT) and bicalutamide (BIC) on the human prostate cancer cell line LNCaP in vitro...
  9. ncbi request reprint Enterolactone as a risk factor for breast cancer: a review of the published evidence
    Francesco Boccardo
    University of Genoa, Genoa, Italy
    Clin Chim Acta 365:58-67. 2006
    ..In summary, epidemiological evidence to date is conflicting. Prospective large scale studies will require assessing the consumption of antibiotics and dietary habits during adolescence in order to obtain definitive conclusions...
  10. ncbi request reprint Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial
    Francesco Boccardo
    National Cancer Research Institute, 16132 Genoa, Italy
    J Clin Oncol 23:5138-47. 2005
    ..Moreover, many women relapse during or after tamoxifen therapy because of the development of resistance. Therefore new approaches are required...
  11. ncbi request reprint Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer
    F Boccardo
    University and National Cancer Research Institute, University of Genoa, Genoa, Italy
    J Clin Oncol 23:808-15. 2005
    ..To determine whether tamoxifen or anastrozole prevents gynecomastia and breast pain caused by bicalutamide (150 mg) without compromising efficacy, safety, or sexual functioning...
  12. ncbi request reprint Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer
    Francesco Boccardo
    Professorial Unit of Medical Oncology, University and National Cancer Research Institute, Largo R Benzi 10, 16132, Genoa, Italy
    Cancer Chemother Pharmacol 56:415-20. 2005
    ....
  13. doi request reprint Prognostic value of nuclear matrix protein expression in localized prostate cancer
    Francesco Ricci
    Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
    J Cancer Res Clin Oncol 138:1379-84. 2012
    ..The aim of the study was to correlate nuclear matrix (NM) protein expression profiles with the risk of PSA progression or death in early prostate cancer (PCa)...
  14. pmc Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death
    Pier Vitale Nuzzo
    IRCCS San Martino University Hospital IST National Cancer Research Institute and the University of Genoa, Academic Unit of Medical Oncology UOC Oncologia Medica B, Largo Rosanna Benzi 10, 16132 Genoa, Italy
    BMC Cancer 12:625. 2012
    ..The purpose of the present study was to evaluate the prognostic value of POSTN expression following prostatectomy...
  15. ncbi request reprint Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell line
    Rosa Mangerini
    Department of Medical Oncology, IRCCS SAN Martino Hospital IST National Cancer Research Institute, Largo R Benzi 10, 16132 Genoa, Italy
    Anticancer Res 32:5323-9. 2012
    ..Breast events are common adverse effects which can be effectively prevented by the concurrent administration of tamoxifen, a selective estrogen receptor modulator...
  16. doi request reprint An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients
    Davide Bedognetti
    University of Genoa, Genoa, Italy
    Eur Urol 57:238-45. 2010
    ..To reduce the exposure to tamoxifen, we considered the putative advantages of weekly administration...
  17. ncbi request reprint HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study
    Elena Verri
    Academic Department of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Oncology 68:154-61. 2005
    ..Prior studies have shown that HER2/neu oncogene is overexpressed in approximately 15-30% of ovarian carcinomas. However findings regarding the overexpression and prognosis are still conflicting...
  18. ncbi request reprint Switching trial of adjuvant tamoxifen with an aromatase inhibitor in postmenopausal patients with breast cancer
    Francesco Boccardo
    University and National Cancer Research Institute, Genoa, Italy
    Clin Breast Cancer 5:S13-7. 2004
    ..The updated results of previous trials and ongoing trials will soon establish criteria for selecting patients who might be better candidates for sequencing, and to fine tune strategies that are more appropriate...
  19. ncbi request reprint Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer: updated results of a multicentric trial
    Francesco Boccardo
    Department of Medical Oncology, University and National Cancer Research Institute of Genoa, Largo R Benzi 10, 16132 Genoa, Italy
    Eur Urol 42:481-90. 2002
    ..To compare the efficacy of bicalutamide monotherapy to maximal androgen blockade in advanced prostatic cancer...
  20. doi request reprint Lymphatic microsurgery to treat lymphedema: techniques and indications for better results
    Francesco Boccardo
    Unit of Lymphatic Surgery, Department of Surgery, IRCCS S Martino University Hospital IST, Genoa, Italy
    Ann Plast Surg 71:191-5. 2013
    ....
  21. ncbi request reprint Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer
    Fabia Galmozzi
    Department of Medical Oncology, University of Genova, Genova, Italy
    J Cancer Res Clin Oncol 132:757-64. 2006
    ....
  22. ncbi request reprint Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials
    Francesco Boccardo
    University and National Cancer Research Institute, Genoa, Italy
    Cancer 109:1060-7. 2007
    ..However, until now not all previous studies have shown a mortality benefit...
  23. doi request reprint Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study
    Pamela Guglielmini
    Department of Oncology, Biology and Genetics, University of Genoa, Genoa, Italy
    Breast Cancer Res Treat 132:661-8. 2012
    ....
  24. doi request reprint Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen receptor-positive breast cancer patients. Very late results of the 'gruppo di ricerca per la chemio-ormonoterapia adiuvante (GROCTA)' 01-Trial in early breast can
    Francesco Boccardo
    Department of Oncology, Biology and Genetics, University of Genoa, Largo Rosanna Benzi 10, Genoa, Italy
    Breast Cancer Res Treat 126:653-61. 2011
    ....
  25. ncbi request reprint Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis
    Paola Barboro
    National Cancer Research Institute, Genoa, Italy
    Cell Oncol 30:13-26. 2008
    ..Our aim was to identify nuclear matrix (NM) proteins that might serve to better characterize the phenotype of the invasive bladder cancer and to investigate their diagnostic and prognostic roles...
  26. doi request reprint Lymphedema microsurgical preventive healing approach for primary prevention of lower limb lymphedema after inguinofemoral lymphadenectomy for vulvar cancer
    Matteo Morotti
    Department of Obstetrics and Gynecology, S Martino Hospital, University of Genoa, Genoa, Italy
    Int J Gynecol Cancer 23:769-74. 2013
    ..This study describes the use of microsurgical lymphatic venous anastomosis (LVA) to prevent LLL in patients with vulvar cancer undergoing inguinofemoral lymph node dissection (ILND)...
  27. doi request reprint Pediatric lymphedema and correlated syndromes: role of microsurgery
    Corradino Campisi
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, San Martino Hospital, University of Genoa, Italy
    Microsurgery 28:138-42. 2008
    ..Better long-term results are obtained in earlier stages...
  28. doi request reprint Microsurgery for groin lymphocele and lymphedema after oncologic surgery
    Francesco Boccardo
    Department of Surgery Unit of Lymphatic Surgery, IRCCS S Martino University Hospital IST, Genoa, Italy
    Microsurgery 34:10-3. 2014
    ..2013 Wiley Periodicals, Inc. Microsurgery 34:10-13, 2014. ..
  29. ncbi request reprint Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk
    Francesco Boccardo
    Professorial Unit of Medical Oncology, University and National Cancer Research Institute, Genoa, Italy
    Breast Cancer Res Treat 79:17-23. 2003
    ..Our results show that enterolactone does accumulate in breast cysts, and that it modulates the risk related to the intracystic level of EGF, which is confirmed to be a strong predictor of breast cancer risk...
  30. doi request reprint Microsurgery for lymphedema: clinical research and long-term results
    Corradino Campisi
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, San Martino Hospital, University of Genoa, Italy
    Microsurgery 30:256-60. 2010
    ..To report the wide clinical experience and the research studies in the microsurgical treatment of peripheral lymphedema...
  31. doi request reprint Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy
    Francesco Boccardo
    Department of Surgery, Unit of Lymphatic Surgery, S Martino Hospital, University of Genoa, 16132 Genoa, Italy
    Ann Surg Oncol 16:703-8. 2009
    ..The purpose of this manuscript is to assess the efficacy of direct lymphatic venous microsurgery in the prevention of lymphedema following axillary dissection for breast cancer...
  32. doi request reprint Epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil versus paclitaxel followed by epirubicin and vinorelbine in patients with high-risk operable breast cancer
    Francesco Boccardo
    National Cancer Research Institute and the University of Genoa Largo Rosanna Benzi 10, IT 16132 Genoa, Italy
    Oncology 78:274-81. 2010
    ..Chemotherapy (CT), alone or combined with endocrine therapy (ET) in hormone receptor (HOR)-positive patients, is the standard for these women. However, there are still questions surrounding the optimal adjuvant CT regimen...
  33. ncbi request reprint The lymphatics in the pathophysiology of thoracic and abdominal surgical pathology: immunological consequences and the unexpected role of microsurgery
    Francesco Boccardo
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, San Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 27:339-45. 2007
    ..All patients had an improvement of their immunocompetence. Median follow-up was 5 years. We demonstrated that the use of microsurgery is remarkably advantageous for performing a causal treatment of the dysfunction...
  34. ncbi request reprint Peripheral lymphedema: new advances in microsurgical treatment and long-term outcome
    Corradino Campisi
    Department of Surgery, Lymphology and Microsurgery Center, S Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 23:522-5. 2003
    ..With a follow-up even over 15 years after surgery, positive results from lymphatic microsurgery can be achieved in more than 80% of cases, especially in patients at precocious stages...
  35. doi request reprint A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
    Daniela Fenoglio
    Centre of Excellence for Biomedical Research, University of Genoa, Viale Benedetto XV n 7, 16132 Genoa, Italy
    Cancer Immunol Immunother 62:1041-52. 2013
    ..GX301 is a vaccine constituted by four telomerase peptides and two adjuvants, Montanide ISA-51 and Imiquimod...
  36. doi request reprint Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast
    Aldo Profumo
    Biopolymers and Proteomics Unit, IRCCS AOU San Martino IST, San Martino University Hospital and National Cancer Research Institute, Genoa, Italy
    J Proteomics 85:44-52. 2013
    ..Higher levels of C3f in the serum of women affected by a benign condition like GCDB thus appears to be correlated to the development of breast cancer even 20 years later...
  37. doi request reprint Diagnostic assessment and therapeutic approach for immunodeficiency due to chylous dysplasia: A case report
    Francesco Boccardo
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, San Martino Hospital, University of Genoa, Italy
    Microsurgery 30:401-4. 2010
    ..An accurate diagnostic assessment and above all lymphangiography allow to diagnose properly difficult cases of immunodeficiency due to intestinal protido-dispersion and to plan a correct therapeutic functional approach...
  38. ncbi request reprint Chemotherapy with cisplatin and 5-fluorouracil chronomodulated infusion in locally advanced or metastatic/recurrent carcinoma of the cervix
    Loredana Miglietta
    Professorial Unit of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Tumori 88:204-8. 2002
    ....
  39. doi request reprint Immunohistochemistry in non-immune hydrops fetalis: a single center experience in 79 fetuses
    Carlo Bellini
    Neonatal Intensive Care Unit, Department of Pediatrics DIPE, Gaslini Institute, University of Genoa, Genova, Italy
    Am J Med Genet A 152:1189-96. 2010
    ..4%; P = 0.01). In conclusion, specific IHC staining techniques aimed at detecting lymphatic dysplasia are needed and should be mandatory in autopsies of fetuses with non-immune hydrops fetalis...
  40. ncbi request reprint Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines
    Laura Emionite
    Department of Oncology, Biology and Genetics, University of Genova, Genova, Italy
    Anticancer Res 24:4019-24. 2004
    ..The efficacy of the retinoids/HDACIs combinations could represent a new strategy in breast cancer chemotherapy, allowing inhibition of both ER + and ER- cell populations...
  41. ncbi request reprint Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives
    Corradino Campisi
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, San Martino Hospital, University of Genoa, Genoa, Italy
    Microsurgery 27:333-8. 2007
    ..Improved results can be expected with operations performed at earlier lymphedema stages...
  42. ncbi request reprint Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications
    Paola Barboro
    National Cancer Research Institute, L go R Benzi 10, 1 16132 Genoa, Italy
    Anticancer Res 25:3999-4004. 2005
    ..In addition, a few newly-expressed proteins are significantly correlated with the risk of biochemical progression. The potential application of these proteins at the diagnostic and prognostic levels calls for further studies...
  43. ncbi request reprint Diagnosis and management of primary chylous ascites
    Corradino Campisi
    Department of Surgery, Lymphatic Surgery and Microsurgery Unit, S Martino Hospital, University of Genoa, Genoa, Italy
    J Vasc Surg 43:1244-8. 2006
    ..Primary chylous ascites is uncommon. We present our experience in the diagnosis and treatment of this condition...
  44. ncbi request reprint Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery
    Corradino Campisi
    Department of Specialistic Surgical Sciences, Anesthesiology, and Organ Transplants, Section of General and Emergency Surgery, Lymphology and Microsurgery Center, S Martino Hospital, University of Genoa, Genoa, Italy
    World J Surg 28:609-13. 2004
    ..Improved results can be expected with operations performed early, during the first stages of lymphedema...
  45. doi request reprint Lymphatic complications in surgery: possibility of prevention and therapeutic options
    Francesco Boccardo
    Department of Surgery, University of Genoa, Lar Genoa, Italy
    Updates Surg 64:211-6. 2012
    ....
  46. doi request reprint Neurinoma originating from the recurrent nerve: report of a case
    Emanuela Varaldo
    Unità Operativa di Chirurgia Generale ad Indirizzo Endocrino, Universita degli Studi di Genova, Largo R Benzi 8, Genoa, Italy
    Surg Today 38:633-4. 2008
    ..This report describes an unusual case of recurrent nerve Schwannoma which was successfully identified by color Doppler sonography...
  47. ncbi request reprint Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report
    Laura Tomasello
    Academic Department of Medical Oncology, National Cancer Research Institute, Genoa, Italy
    Anticancer Res 26:4775-7. 2006
    ..The authors report a case of cutaneous radiation-associated angiosarcoma treated with paclitaxel chemotherapy. A few days after drug administration, bleeding of skin lesions was observed and the patient died...
  48. pmc Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens
    Davide Bedognetti
    Department of Oncology, Biology, and Genetics, University of Genoa, 16132 Genoa, Italy
    J Immunol 186:6044-55. 2011
    ....
  49. doi request reprint Lymphatic dysplasias in newborns and children: the role of lymphoscintigraphy
    Carlo Bellini
    Neonatal Intensive Care Unit, Department of Pediatrics, University of Genoa, G Gaslini Institute, Genoa, Italy
    J Pediatr 152:587-9, 589.e1-3. 2008
    ..We suggest that lymphoscintigraphy is mandatory in all patients with signs of lymphatic dysplasia, including those with minimal and initial signs of lymphatic impairment, to obtain very early diagnosis and begin treatment...
  50. pmc Congenital pulmonary lymphangiectasia
    Carlo Bellini
    Neonatal Intensive Care Unit, Department of Pediatrics, University of Genoa, G, Gaslini Institute, Genoa, Italy
    Orphanet J Rare Dis 1:43. 2006
    ..Recent advances in intensive neonatal care have changed the previously nearly fatal outcome of PL at birth. Patients affected by PL who survive infancy, present medical problems which are characteristic of chronic lung disease...
  51. ncbi request reprint Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia
    Carlo Bellini
    Servizio di Patologia Neonatale, Dipartimento di Pediatria DIPE, Universita di Genoa, Istituto G Gaslini, Largo G Gaslini, 16147 Genoa, Italy
    Am J Med Genet A 120:92-6. 2003
    ..Hydrops fetalis may be present in newborns with the Hennekam syndrome. Lymphoscintigraphy can be useful in explaining pleural-pulmonary involvement of this generalized lymph vessel malformation syndrome...
  52. ncbi request reprint [Prevention of lymphoedema secondary to the treatment of breast cancer: a case report and proposal for a prevention protocol]
    Corradino Campisi
    Dipartimento di Chirurgia, Sezione di Chirurgia dei Linfatici e Microchirurgia, Ospedale S Martino, Universita degli Studi di Genova
    Chir Ital 56:419-24. 2004
    ....
  53. ncbi request reprint Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis
    Walter Jonat
    University of Kiel, Germany
    Lancet Oncol 7:991-6. 2006
    ..We aimed to investigate whether switching treatment of postmenopausal women with such breast cancer to anastrozole after 2-3 years of tamoxifen would be more effective than continuing on tamoxifen for a total of 5 years...
  54. ncbi request reprint Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia
    Carlo Bellini
    Servizio di Patologia Neonatale, Dipartimento di Pediatria DIPE, Universita di Genova, Istituto G Gaslini, Genova, Italia
    Am J Med Genet A 140:678-84. 2006
    ....
  55. ncbi request reprint Differential expression of nuclear lamins in normal and cancerous prostate tissues
    Rosella Coradeghini
    Istituto Nazionale per la Ricerca sul Cancro, I 16132 Genova, Italy
    Oncol Rep 15:609-13. 2006
    ....
  56. ncbi request reprint Lymphoscintigraphic evaluation of congenital lymphedema of the newborn
    Carlo Bellini
    Neonatal Intensive Care Unit, Department of Pediatrics, the Institute G Gaslini, University of Genova, Genova, Italy
    Clin Nucl Med 27:383-4. 2002
  57. ncbi request reprint Impact of concurrent radiotherapy on chemotherapy total dose and dose intensity in patients with early breast cancer
    Cristina Marenghi
    University and National Cancer Research Institute of Genoa, Italy
    Tumori 91:126-30. 2005
    ..A retrospective analysis was conducted to evaluate the tolerability as well as the impact of concurrent adjuvant CMF chemotherapy and radiation therapy on total CMF dose and dose intensity...
  58. ncbi request reprint Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer
    Francesco Boccardo
    Professorial Unit of Medical Oncology, University and National Cancer Research Institute of Genoa, Italy
    Prostate 55:259-64. 2003
    ....